Specific degrader for fusion oncokinase kills tumors and is augmented by bimodal degrader-siRNA
Mahsa Shirani, Ronaldo Shaquille Bowie, Michael D. Tomasini, Ruth Hook, Denise Ng, Bassem Shebl, Barbara A. Lyons, Philip Coffino, Sanford M. Simon
The paper develops a degrader that specifically targets oncogenic fusions in cancer cells, showing efficacy in preclinical models and enhanced therapeutic effect when combined with siRNA.
bioRxiv · Apr 24, 2025 · PreprintCancer Biology